首页工具

GSK-3

Glycogen synthase kinase 3 is a serine/threonine protein kinase that mediates the addition of phosphate molecules onto serine and threonine amino acid residues. First discovered in 1980 as a regulatory kinase for its namesake, Glycogen synthase, GSK-3 has since been identified as a kinase for over 100 different proteins in a variety of different pathways. In mammals GSK-3 is encoded by two paralogous genes, GSK-3 alpha (GSK3A) and GSK-3 beta (GSK3B). GSK-3 has recently been the subject of much research because it has been implicated in a number of diseases, including Type II diabetes (diabetes mellitus type 2), Alzheimer's disease, inflammation, cancer, and bipolar disorder.

Cat. No.	Product Name	CAS No.	Purity
T9987	GSK3-IN-1 化合物 GSK3-IN-1	478482-74-5	98%
T9987	GSK3-IN-1是一种 GSK3B-糖原合酶激酶3β抑制剂。
T10608	BRD5648 化合物BRD5648	2056261-42-6	98%
T10608	BRD5648 ((R)-BRD0705) 是 BRD0705 的阴性对照，BRD0705 是旁系选择性和口服有效的 GSK3α 抑制剂，Kd 为 4.8 μM，IC50为 66 nM。与 GSK3β (IC50为 515 nM) 相比，BRD0705 对 GSK3α 的选择性更高 (8 倍)。BRD0705 可用于急...
T66175	Ceftriaxone Sodium Ceftriaxone 钠盐	958633-51-7	98%
T66175	Ceftriaxone Sodium 是一种广谱 β-内酰胺类三代头孢菌素类抗生素 (antibiotic)，具有抗炎、抗肿瘤、抗菌和抗氧化活性。Ceftriaxone Sodium 是一种共价 GSK3β和 Aurora B 抑制剂，可用于研究败血症和感染性心内膜炎。